Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01341067 · ClinicalTrials.gov registry record
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes
A clinical trial of Type 2 Diabetes Mellitus, sponsored by Rocky Mountain Diabetes and Osteoporosis Center.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT01341067 is a study of Type 2 Diabetes Mellitus that has completed, run by Rocky Mountain Diabetes and Osteoporosis Center. The registered enrollment target is 30 participants, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01341067, a study of Type 2 Diabetes Mellitus, has completed, sponsored by Rocky Mountain Diabetes and Osteoporosis Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effect CGM (continuous glucose monitoring) has on subjects with type 2 diabetes. It is anticipated that patients using the device will obtain tighter control of their blood sugars resulting in measureable health benefits and improved confidence in their ability to manage their diabetes.
Conditions Studied
Study Locations (1)
Idaho
- Rocky Mountain Diabetes and Osteoporosis Center - Idaho Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01341067
The ClinicalTrials.gov registry entry for NCT01341067 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The listed sponsor is Rocky Mountain Diabetes and Osteoporosis Center, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 0 interventions.
NCT01341067 reports 1 study location spanning 1 distinct geographic area - top geographies include Idaho.
Frequently Asked Questions
What is clinical trial NCT01341067 about?
NCT01341067 is a clinical study titled "Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes". The purpose of this study is to examine the effect CGM (continuous glucose monitoring) has on subjects with type 2 diabetes. It is anticipated that patients using the device will obtain tighter control of their blood sugars resulting in measureable health benefits and improved confidence in their ab...
What is the current status of trial NCT01341067?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2011-04. Estimated completion is 2011-12.
What conditions does trial NCT01341067 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.
Who is sponsoring clinical trial NCT01341067?
This trial is sponsored by Rocky Mountain Diabetes and Osteoporosis Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01341067 being conducted?
This trial has 1 study location across Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System
RECRUITING
-
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 1
-
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
RECRUITING
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
RECRUITING
-
A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.